You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RXRX Sale Disclosure
Gibson Christopher · SEC Form 4 · Filed Jun 5, 2026
Sale
Calculated transaction value
$144.8K
Gibson Christopher Director
RXRX
Transaction date
Jun 5, 2026
Public filing date
Jun 5, 2026
Filing lag
Filed same day
RXRX daily price context
Close on/before transaction
$3.31
Jun 5, 2026
First close after public filing
$3.32
Jun 8, 2026
30-day return after filing
+19.28%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 40,000 shares @ $3.62
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001856369-26-000023
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$144.8K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX | Conversion | Jun 5, 2026 | $0 |
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Jun 5, 2026 | $144.8K |
| Recursion Pharmaceuticals, Inc. RXRX | Conversion | Jun 5, 2026 | $0 |